Yahoo Finance • 15 days ago
AUSTIN, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonar... Full story
Yahoo Finance • 29 days ago
* Rein Therapeutics (NASDAQ:RNTX [https://seekingalpha.com/symbol/RNTX]) filed to sell 10M shares of common stock for holders. * Filing [https://seekingalpha.com/filing/10383745] MORE ON AILERON THERAPEUTICS * Rein Therapeutics... Full story
Yahoo Finance • last month
LONDON - Rein Therapeutics (NASDAQ:RNTX), a clinical-stage biotech company currently valued at $26 million, announced Tuesday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of its Phase... Full story
Yahoo Finance • last month
AUSTIN, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fi... Full story
Yahoo Finance • 2 months ago
AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary... Full story